ClinicalTrials.gov
ClinicalTrials.gov Menu

Panobinostat in Combination With Idarubicin and Cytarabine in Patients Aged 65 Years or Older With Newly Diagnosed Acute Myeloblastic Leukaemia (AML) (PANOBIDARA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00840346
Recruitment Status : Completed
First Posted : February 10, 2009
Last Update Posted : May 17, 2016
Sponsor:
Information provided by:
PETHEMA Foundation